Tue, 22nd Sep 2020 12:56
(Sharecast News) - Fevertree slumped on Tuesday after RBC Capital Markets downgraded its stance on shares of the posh tonics maker to 'sector perform' from 'outperform' and slashed the price target from 2,600p.
Read more(Sharecast News) - Fevertree: RBC Capital Markets downgrades to sector perform with a target price of 2,000p.
Read moreAIM WINNERS & LOSERS: Mediazest jumps as new business wins roll in
Read moreBROKER RATINGS: BAE Systems, Entain and Ryanair get upgrades
Read moreLONDON BRIEFING: JD Wetherspoon promises new pubs if no more lockdowns
Read moreBROKER RATINGS: Morgan Stanley upgrades BT to Overweight
Read more(Sharecast News) - Fevertree: Barclays upgrades to buy with a target price of 2,500p.
Read moreBROKER RATINGS: Goldman Sachs cuts Kingfisher and raises Bodycote
Read more(Sharecast News) - Fevertree: Numis upgrades to buy with a target price of 2,800p.
Read moreBROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson
Read moreLONDON MARKET CLOSE: Stocks boosted by supportive central banks
Read moreLONDON MARKET MIDDAY: Shares lower; BoE to keep loose monetary policy
Read moreFevertree Drinks profit sinks as pub closures take fizz out of sales
Read moreAIM WINNERS & LOSERS: Fevertree Drinks loses fizz on margin guidance
Read more